Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Agata, Braniewska"'
Autor:
Zofia Pilch, Katarzyna Tonecka, Marcin Skorzynski, Zuzanna Sas, Agata Braniewska, Tomasz Kryczka, Louis Boon, Jakub Golab, Linde Meyaard, Tomasz P Rygiel
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210796 (2019)
Tumor-infiltrating immune cells can impact tumor growth and progression. The inhibitory CD200 receptor (CD200R) suppresses the activation of myeloid cells and lack of this pathway results in a reduction of tumor growth, conversely a tumorigenic effec
Externí odkaz:
https://doaj.org/article/d9f6c664323840f883c0c96f1cf2f99a
Autor:
Katarzyna Tonecka, Agata Braniewska, Zofia Pilch, Zuzanna Sas, Marcin Skorzynski, Elisabetta Manuali, Tomasz P. Rygiel
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 10, p 5358 (2021)
Inflammatory bowel disease is characterized by the infiltration of immune cells and chronic inflammation. The immune inhibitory receptor, CD200R, is involved in the downregulation of the activation of immune cells to prevent excessive inflammation. W
Externí odkaz:
https://doaj.org/article/07f5051efa644d3fa999c3f621060f5c
Autor:
Łukasz Kiraga, Gabriele Cerutti, Agata Braniewska, Damian Strzemecki, Zuzanna Sas, Alberto Boffi, Carmelinda Savino, Linda Celeste Montemiglio, Daniel Turnham, Gillian Seaton, Alessandra Bonamore, Richard Clarkson, Adam M. Dabkowski, Stephen J. Paisey, Bartłomiej Taciak, Paulina Kucharzewska, Tomasz P. Rygiel, Magdalena Król
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 14, p 4991 (2020)
Proteins, as a major component of organisms, are considered the preferred biomaterials for drug delivery vehicles. Hemoglobin (Hb) has been recently rediscovered as a potential drug carrier, but its use for biomedical applications still lacks extensi
Externí odkaz:
https://doaj.org/article/de665128ffa64fbf93d9d13de855cdaf
Autor:
Bartłomiej Taciak, Maciej Białasek, Agata Braniewska, Zuzanna Sas, Paulina Sawicka, Łukasz Kiraga, Tomasz Rygiel, Magdalena Król
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198943 (2018)
Established cell lines are widely used in research, however an appealing question is the comparability of the cells between various laboratories, their characteristics and stability in time. Problematic is also the cell line misidentification, geneti
Externí odkaz:
https://doaj.org/article/46cdee6a59fa489dad2a3f71283eb97b
Autor:
Tomasz M, Rywik, Agata, Braniewska, Ilona, Kowalik, Małgorzata, Firczuk, Katarzyna, Kozar-Kamińska, Anna, Wojciechowska, Anna, Kasprzyk-Pawelec, Małgorzata, Sobieszczańska-Małek, Przemysław, Leszek, Piotr, Rozentryt, Tomasz, Zieliński
Publikováno v:
Polish archives of internal medicine. 129(12)
Endothelial progenitor cells (EPCs) in nontransplant settings have reparative properties. However, their role in heart transplantation (HT) is not well defined.The aim of this study was to prospectively evaluate changes in EPC levels in relation to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d180e8916e89ce273c67871e7f63ec6e
https://pubmed.ncbi.nlm.nih.gov/31777401
https://pubmed.ncbi.nlm.nih.gov/31777401
Autor:
Ilona Kowalik, Katarzyna Kozar-Kamińska, Tomasz Rywik, Przemysław Leszek, Anna Wojciechowska, Agata Braniewska, Piotr Rozentryt, Małgorzata Sobieszczańska-Małek, Tomasz Zieliński, Anna Kasprzyk-Pawelec, Malgorzata Firczuk
Publikováno v:
Polish Archives of Internal Medicine.
INTRODUCTION Endothelial progenitor cells (EPCs) in nontransplant settings have reparative properties. However, their role in heart transplantation (HT) is not well defined. OBJECTIVES The aim of this study was to prospectively evaluate changes in EP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4d92fa6daee72c1fac34e74292d8cd2
https://doi.org/10.20452/pamw.15072
https://doi.org/10.20452/pamw.15072
Autor:
M Sobieszczanska-Malek, A Kasprzyk-Pawelec, T. Rywik, I Kowalik, A Wojciechowska, Tomasz Zieliński, Przemysław Leszek, Piotr Rozentryt, K Kozar-Kaminska, Malgorzata Firczuk, Agata Braniewska
Publikováno v:
European Heart Journal. 40
Background The role of endothelial progenitor cells (EPC) in heart transplantation (HT) is not well defined. Thus, the aim of this study was to evaluate prospectively the dynamic changes of circulating EPC levels in relation to post-HT rejection risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a282e8d35e59d2beac2ef24a835f517
https://doi.org/10.1093/eurheartj/ehz747.0352
https://doi.org/10.1093/eurheartj/ehz747.0352
Autor:
Katarzyna Tonecka, Joanna Stachura, Agata Braniewska, Angelika Muchowicz, Jakub Golab, Louis Boon, Tomasz P. Rygiel, Malgorzata Wachowska, Iwona Kotuła, Zuzanna Sas, Klaudyna Fidyt
Publikováno v:
Cancer Immunology, Immunotherapy
It was previously reported that the activation of antitumor immune response by photodynamic therapy (PDT) is crucial for its therapeutic outcome. Excessive PDT-mediated inflammation is accompanied by immunosuppressive mechanisms that protect tissues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4376ad626b4ba0f3882a60707487792d
https://pubmed.ncbi.nlm.nih.gov/32107566
https://pubmed.ncbi.nlm.nih.gov/32107566
Autor:
Łukasz Cheda, Zbigniew Rogulski, Magdalena Król, Paulina Kucharzewska-Siembieda, Łukasz Kiraga, Emilia Górka, Małgorzata Kubiak, Michał M. Godlewski, Zuzanna Sas, Agata Braniewska, Maciej Białasek, Tomasz P. Rygiel, Aleksandra Szulc, Bartłomiej Taciak, Zofia Pilch, Katarzyna Tonecka, Alberto Boffi
Publikováno v:
Cancer Immunology Research. 8:B24-B24
Unsatisfactory response of tumors to chemotherapy is mainly related to impaired diffusion of the anticancer drug because of decreased drug uptake due to poor vasculature. Moreover, the drug is not able to penetrate the most hypoxic sites. Cells from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a539b8efaf3bb17435f9d93f129d166
https://doi.org/10.1158/2326-6074.tumimm18-b24
https://doi.org/10.1158/2326-6074.tumimm18-b24
Autor:
Katarzyna Tonecka, Louis Boon, Marcin Skorzynski, Zofia Pilch, Tomasz Kryczka, Agata Braniewska, Zuzanna Sas, Tomasz P. Rygiel, Linde Meyaard, Jakub Golab
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 1, p e0210796 (2019)
PLoS ONE, 14(1). Public Library of Science
PLOS ONE
PLoS ONE, Vol 14, Iss 1, p e0210796 (2019)
PLoS ONE, 14(1). Public Library of Science
PLOS ONE
Tumor-infiltrating immune cells can impact tumor growth and progression. The inhibitory CD200 receptor (CD200R) suppresses the activation of myeloid cells and lack of this pathway results in a reduction of tumor growth, conversely a tumorigenic effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca941ef4f673505743ca9aa440b7cf9e
https://pubmed.ncbi.nlm.nih.gov/30653571
https://pubmed.ncbi.nlm.nih.gov/30653571